Compare SRRK & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | MHK |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.2B |
| IPO Year | 2018 | 1995 |
| Metric | SRRK | MHK |
|---|---|---|
| Price | $44.36 | $108.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $56.17 | ★ $126.10 |
| AVG Volume (30 Days) | ★ 1.0M | 596.3K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.90 |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $3.38 |
| Revenue Next Year | $534.24 | $3.09 |
| P/E Ratio | ★ N/A | $56.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.07 | $92.99 |
| 52 Week High | $52.19 | $143.13 |
| Indicator | SRRK | MHK |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 56.90 |
| Support Level | $42.52 | $105.29 |
| Resistance Level | $48.23 | $112.76 |
| Average True Range (ATR) | 2.10 | 3.34 |
| MACD | -0.36 | 0.47 |
| Stochastic Oscillator | 14.24 | 78.76 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.